CAP

MAKO Medical Selected for Kentucky K-12 School COVID-19 Testing

Retrieved on: 
Tuesday, August 10, 2021

KENTUCKY, Aug. 10, 2021 (GLOBE NEWSWIRE) -- The Kentucky Department for Public Health (KDPH) has selected MAKO Medical as one of the testing partners to provide COVID-19 testing for all Kentucky students and educators throughout the 2021/2022 school year.

Key Points: 
  • KENTUCKY, Aug. 10, 2021 (GLOBE NEWSWIRE) -- The Kentucky Department for Public Health (KDPH) has selected MAKO Medical as one of the testing partners to provide COVID-19 testing for all Kentucky students and educators throughout the 2021/2022 school year.
  • MAKO Medical is ready to help Kentucky schools safely reopen, Josh Arant, Chief Operating Officer, MAKO Medical.
  • In partnership with the CDC, the KDPH has launched the Kentucky K-12 School COVID-19 Testing Program .
  • Research shows regular weekly testing of students and educators reduces the spread of COVID-19 in schools by 50%, Ryan Nibert, Regional Executive, MAKO Medical.

mLogica Acquires Innovative Legacy Modernization Firm Reverse Paradigm, Augmenting Their Recent Acquisition of the LIBER Software Suite from Atos

Retrieved on: 
Tuesday, August 10, 2021

Its a move made possible by their recent acquisition of pioneering Italian mainframe technology firm Reverse Paradigm, as well as several other strategic purchases of key technology players and assets earlier this year.

Key Points: 
  • Its a move made possible by their recent acquisition of pioneering Italian mainframe technology firm Reverse Paradigm, as well as several other strategic purchases of key technology players and assets earlier this year.
  • This follows mLogicas recent acquisition of the groundbreaking LIBER software suite from French multinational information technology firm Atos.
  • With these purchases of Reverse Paradigm and the LIBER suite, mLogica is now the one firm that can provide end-to-end expertise, tools and support for every phase of modernization to the cloud.
  • mLogica leverages its automated distributed systems modernization software suite STAR*M , and their mainframe modernization software, LIBER*M , to migrate legacy systems to the cloud.

Fulgent Genetics Announces Acquisition of CSI Laboratories

Retrieved on: 
Monday, August 9, 2021

Fulgent Genetics, Inc. (NASDAQ: FLGT) (Fulgent or the Company), a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, today announced that it has acquired CSI Laboratories (CSI) to expand its presence in somatic molecular diagnostics and cancer testing.

Key Points: 
  • Fulgent Genetics, Inc. (NASDAQ: FLGT) (Fulgent or the Company), a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, today announced that it has acquired CSI Laboratories (CSI) to expand its presence in somatic molecular diagnostics and cancer testing.
  • CSI offers more than 400 unique tests with a focus on oncology and capabilities across flow cytometry, cytogenetic analysis, fluorescence in-situ hybridization (FISH), immunohistochemistry, and molecular genetics.
  • - Expansion into somatic genetic testing market, which is expected to grow to $16.8 billion by 2030
    With the acquisition of CSI, Fulgent will significantly expand its capabilities in molecular diagnostics and oncologic testing.
  • We are extremely excited to add CSI Laboratories expertise and team to the Fulgent family, said Ming Hsieh, Chairman and CEO of Fulgent.

Cooperative of American Physicians Names Margaret Martin as Vice President, Risk Management & Patient Safety

Retrieved on: 
Monday, August 9, 2021

LOS ANGELES, Aug. 09, 2021 (GLOBE NEWSWIRE) -- The Cooperative of American Physicians, Inc. (CAP) today announced the appointment of Margaret A. Martin, RN, JD as its new Vice President, Risk Management & Patient Safety.

Key Points: 
  • LOS ANGELES, Aug. 09, 2021 (GLOBE NEWSWIRE) -- The Cooperative of American Physicians, Inc. (CAP) today announced the appointment of Margaret A. Martin, RN, JD as its new Vice President, Risk Management & Patient Safety.
  • Ms. Martin will be responsible for leading CAPs Risk Management & Patient Safety team and delivering risk management and patient safety education and services to CAPs 12,000 physician members and their practices, as well as the medical groups, hospitals, and facilities served by CAPAssurance, a Risk Purchasing Group, covering an additional 3,000 physicians.
  • Margaret has a proven track record of achieving improvements in performance, risk management, patient safety, and patient outcomes.
  • The Cooperative of American Physicians, Inc. (CAP), established in 1975, offers medical professional liability protection to some 12,000 of California's finest physicians through the Mutual Protection Trust.

Global Billboard and Outdoor Advertising Market (2021 to 2030) - COVID-19 Impact and Recovery

Retrieved on: 
Friday, August 6, 2021

It places the market within the context of the wider billboard and outdoor advertising market, and compares it with other markets.

Key Points: 
  • It places the market within the context of the wider billboard and outdoor advertising market, and compares it with other markets.
  • It compares the billboard and outdoor advertising market with other segments of the billboard and outdoor advertising market by size and growth, historic and forecast.
  • Major players in the billboard and outdoor advertising market are JCDecaux, Capitol Outdoor LLC, Clear Channel Outdoor Holdings Inc, Lamar Advertising Co., OUTFRONT Media Inc., and Focus Media.
  • Global Billboard and Outdoor Advertising Market, Split by Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
    7.2.

Insights on the $60.23 Billion Billboard and Outdoor Advertising Global Market to 2030 - Identify Growth Segments for Investment - ResearchAndMarkets.com

Retrieved on: 
Friday, August 6, 2021

Moreover, the acquisition is expected to help Lamar set its foot strong in the market with 5% anticipated sales growth.

Key Points: 
  • Moreover, the acquisition is expected to help Lamar set its foot strong in the market with 5% anticipated sales growth.
  • Fairway Outdoor Advertising is an American outdoor advertising firm engaged in providing billboards, digital displays, and posters.
  • The increase in digital out of home (DOOH) advertising is expected to contribute to the growth of the billboard and outdoor advertising market.
  • Several regulatory standards employed by governments across the globe for advertising at particular locations or spaces are a key factor hampering the growth of the global billboard and outdoor advertising market.

The Movie Studio Executes Strategic Partnership and Distribution Agreement with Adler & Associates Entertainment and Joint Venture with Max Sound Corporation for Enhanced Audio Processing of The Movie Studio, Inc. Motion Pictures

Retrieved on: 
Thursday, August 5, 2021

The agreement with Max Sound pertains to enhancing audio processing of current motion pictures owned and licensed by The Movie Studio, Inc. via the Companys app, as well as upcoming motion pictures currently in development for The Movie Studios over-the-top (OTT) video streaming platform and app.

Key Points: 
  • The agreement with Max Sound pertains to enhancing audio processing of current motion pictures owned and licensed by The Movie Studio, Inc. via the Companys app, as well as upcoming motion pictures currently in development for The Movie Studios over-the-top (OTT) video streaming platform and app.
  • The Movie Studio is a first-mover digital disruptor operating an over-the-top (OTT) video platform and utilizes blockchain technology for foreign licensing of content for distribution.
  • "A&AE believes that is the first step into what will be a very prosperous long-term synergy between our two innovative companies.
  • HD Audio is a registered trademark of Max Sound Corp. All other trademarks are the property of their respective owners.

Cystic Fibrosis Drug Pipeline Research Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Thursday, August 5, 2021

The "Cystic Fibrosis - Pipeline Insight, 2021" clinical trials has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cystic Fibrosis - Pipeline Insight, 2021" clinical trials has been added to ResearchAndMarkets.com's offering.
  • This Cystic Fibrosis - Pipeline Insight, 2021 provides comprehensive insights about 60+ companies and 60+ pipeline drugs in Cystic Fibrosis pipeline landscape.
  • This segment of the report provides insights about the different Cystic Fibrosis drugs segregated based on following parameters that define the scope of the report, such as:
    There are approx.
  • Cystic Fibrosis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration.

Granite Awarded $64 Million Road Separation Contract in Southern California

Retrieved on: 
Wednesday, August 4, 2021

Granite (NYSE:GVA) has been awarded a $64 million contract for the Jurupa Road Grade Separation project by the Riverside County Transportation Department in Jurupa Valley, California.

Key Points: 
  • Granite (NYSE:GVA) has been awarded a $64 million contract for the Jurupa Road Grade Separation project by the Riverside County Transportation Department in Jurupa Valley, California.
  • The contract award was included in Granites second quarter committed and awarded projects (CAP).
  • The scope of work includes separating Jurupa Road and the Union Pacific Railroad by constructing a grade separation and relocating existing rail spurs.
  • Granite is an industry leader in safety and an award-winning firm in quality and sustainability.

CAP Opens Updated Draft Guideline for Public Comment

Retrieved on: 
Wednesday, August 4, 2021

An expert panel has drafted updated recommendations, which are now open for comment from August 4-August 25, 2021.

Key Points: 
  • An expert panel has drafted updated recommendations, which are now open for comment from August 4-August 25, 2021.
  • Updating the guideline is vital given that IHC testing is an essential component of the pathologic evaluation of many specimens.
  • The updated draft guidance differs from the original guideline due to a change in methodology.
  • Following the open comment period, the panel will consider all feedback to finalize the recommendations, which will be formally published as an updated guideline.